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INTRODUCTION
Autopsy studies showed that an estimated 2-3%
of the population has an incidental asymptomatic
meningioma (1). With the wider use of CT and MRI,
many meningiomas are discovered as incidental
findings during work-up for unrelated symptoms
(2). The majority of incidental menigiomas show
no or minimal growth, therefore they can be safely
observed with follow-up imaging until they grow
significantly or become symptomatic (3-6). How-
ever, it is well known that some of them grow rap-
idly (4, 7, 8). Few authors have investigated patho-
logical features of incidental meningiomas. The pur-
pose of this study was to distinguish pathological
features of incidentally-found growing meningiomas
by comparing incidentally-found with symptomatic
meningiomas.
MATERIALS AND METHODS
One hundred and thirty-two consecutive patients
with non-recurrent meningiomas were surgically
treated in our Department of Neurosurgery be-
tween 2005 and 2007. The medical records of these
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patients were reviewed retrospectively.
The menigiomas were divided into three catego-
ries : incidentally-found growing meningiomas (IG),
incidentally-found meningiomas(I), and sympto-
matic meningiomas (S). Incidentally-found men-
ingiomas initially treated conservatively and finally
removed surgically due to an increase in size were
defined as IG. No meningiomas were previously
treated by gamma knife radiosurgery. Incidentally-
found menigiomas removed without a follow-up pe-
riod were defined as I. Meningiomas surgically re-
moved due to symptoms caused by the tumors were
defined as S.
Radiological features were analyzed by CT scans
and/or MRI. The position of the tumor was classi-
fied as follows : convexity, falx, parasagittal, sylvian
fissure, tentorial, ventricular, foramen magnum, ol-
factory groove, petroclival, petrous, sphenoid ridge,
and tuberculum sellae. The latter six positions were
considered to be the skull base. The tumor volume
was calculated using the formula : lengthdepth
width0.5 (2) on the enhanced MRI. Based on con-
ventional CT and bone window CT, patients were
divided into two groups according to the low den-
sity area around the tumor and calcification in the
tumor.
The tumors were histologically classified accord-
ing to the World Health Organization classification
of tumors (9). An avidin-biotin immunoperoxidase
or simple stain MAX-peroxidase (Nichirei, Tokyo)
technique was used to perform MIB-1 monoclonal
antibody (DAKO, Denmark) assay in selected sec-
tions of each case (10). All tissue sections were ex-
amined at high-power magnification (400). The
number of cells stained positively with MIB-1 and
the total number of tumor cells were counted in
several representative fields containing more than
1000 cells. Their ratio was indicated as the MIB-1
staining index (%).
STATISTICAL ANALYSIS
All data were stored on a personal computer and
analyzed using commercially available statistical soft-
ware (SPSS version 12.0, SPSS Inc.). Chi-square
analysis was used to compare characteristics and
histological grades of patients with meningioma be-
tween all three groups. The student t-test was ap-
plied to compare the MIB-1 staining index between
two groups of three. Significance was judged at a
value of p0.05 for all analyses.
RESULTS
Table 1 shows the characteristics of 19 inciden-
tally-found growing, 50 incidentally-found, and 63
symptomatic meningiomas. Six out of 19 patients
of incidentally-found growing meningioma became
symptomatic during observation. Three suffered
from convulsions, two patients developed cranial
nerve palsy and one developed an exophthalmus.
The average initial and final maximum diameters
of these tumors in an axial plane were 17.6 and
24.6 mm during an average follow-up period of 3.7
years. The average maximum diameter increase of
was 3.7 mm per year. Fifty-one patients with men-
ingioma were over 60 years of age ; 33 patients
were male ; 69 were symptomatic ; 65 meningiomas
were located at the skull base ; 31 were more than
20 cm3 in volume ; 43 had an accompanying edema ;
39 meningiomas showed signs of calcification. The
difference in incidence at the skull base and the
tumor volume were statistically significant between
the groups (IG, I, S).
Table 2 shows the histological subtypes of the
132 surgically-treated meningiomas. There is a sig-
nificant difference of the incidence of WHO grades
I, II, and III between all three groups (p=0.035).
The number of WHO grade II and III were 4 and 1
in 19 IG meningiomas ; one and zero in 50 I men-
ingiomas ; and 4 and 2 in 63 S meningiomas. The
incidence of grades II and III meningiomas in IG,
Table 1 Characteristics of the incidentally - found growing (IG),
incidentally - found (I), and symptomatic (S) meningiomas
Group
Factor IG I S
Age (years) -49 2 15 23
50- 9 14 18
60- 3 18 11
70- 5 3 11
Sex male/female 6/13 8/24 19/44
Symptomatic yes/no 6/13 0/50 63/0
Skull base* yes/no 7/12 19/31 39/24
Volume* -9.9 15 27 18
10- 2 14 17
20- 2 7 24
Edema yes/no 5/14 13/37 25/38
Calcification yes/no 6/13 18/32 15/48
Tatal 19 50 63
*p0.05
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I, and S group were 26%, 2%, and 10%, respectively.
We compared the MIB-1 staining index between
all three groups : the average was 3.8% in IG, 1.3%
in I, and 2.4% in S meningiomas (Figure 1). There
were statistically significant differences of MIB-1
staining index between IG and I, I and S, but not
between IG and S. Two incidentally-found growing
meningiomas are shown in Figure 2.
DISCUSSION
In our study we were able to show that the inci-
dence of WHO grades II and III meningiomas in IG
was 26%, much higher than that of the I and S
groups. The average MIB-1 staining index in IG was
3.8%, also higher than that found in the I and S
groups. It would have been ideal if we could have
compared the pathological characteristics between
growing and non-growing incidental meningiomas.
Retrospectively, we divided surgically-treated men-
ingiomas into three categories and compared the
pathological features. Meaning that incidentally-found
(I) meningiomas removed without a follow-up period
may include those of a growing type. However, the
difference of pathological feature between IG and I
meningiomas was clear. These findings indicate that
Table 2 Histological subtypes of the incidentally - found grow-
ing (IG), incidentally - found (I), and symptomatic (S) men-
ingiomas.
Group
Subtype IG I S
Grade I 14 49 57
Meningothelial 6 18 31
Fibrous 4 19 7
Transitional 4 7 15
Psammomatous 0 0 0
Angiomatous 0 4 1
Microcystic 0 0 0
Secretory 0 1 1
Lymphoplasmacyte-rich 0 0 1
Metaplastic 0 0 1
Grade II 4 1 4
Atypical 3 1 4
Chordoid 1 0 0
Grade III 1 0 2
Rhabdoid 0 0 0
Papillary 0 0 0
Anaplastic 1 0 2
Total 19 50 63
There is a significant difference of the incidence of WHO grades
I, II, and III between the three groups (p=0.035).
Fig. 1 Comparison of the MIB-1 staining index (mean+stan-
dard deviation) between incidentally - found growing (IG), inci-
dentally-found (I), and symptomatic (S) meningiomas. There are
statistically significant differences of MIB -1 staining index be-
tween IG and I, and I and S, but not IG and S.
Fig. 2 An anterior skull base meningioma with calcification was
incidentally found in an 83 year-old woman 8 years ago (upper
left panel). She underwent surgery because of the increase in
size (upper right panel) and subsequently the tumor was diag-
nosed as meningothelial meningioma with a MIB-1 index of 3.2%.
A small right-sided parasagittal meningioma was detected dur-
ing a routine check-up in February of 2003 (lower left panel). The
size of the tumor increased significantly developing perifocal
edema during a course of 3 years (lower right panel). The tumor
was diagnosed as an atypical meningioma (MIB-1 index=11.6%).
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meningiomas that have evidence of growing may
be different from those without, may be biologically
active and include more malignant characteristics.
The natural history of menigiomas has been stud-
ied extensively (4-6, 8, 9, 11-15). The follow-up of
a total of 381 patients with menigioma for an average
of 59 months revealed that the growing rate was
between 17.5-37%, and the rate of change to becom-
ing symptomatic was between 0-17.5%. We now
know that the majority of menigiomas show no or
minimal growth, and can be observed without any
surgical intervention.
Few authors have investigated the relation be-
tween the natural history and the pathological fea-
tures of meningiomas. Jaaskelainen et al. (7) esti-
mated the mean size doubling time of recurrent
meningiomas in 43 patients and found ranges from
450 days for benign, to 205 days for anaplastic tu-
mors, to 178 days for atypical meningiomas. These
results can not be applied to the course of the natu-
ral history of all meningiomas, including non-recur-
rent, as changes in histological morphology and ma-
lignant transformation are known to take place es-
pecially in recurrent meningiomas (2). Therefore,
we highly recommend surgical removal or radiother-
apy for recurrent meningiomasin timely manner.
Recently, Hashiba et al. (16) performed serial
volumetric assessments throughout the follow-up
period for longer than 1 year in 70 patients with
incidentally discovered meningiomas and investi-
gated the growth patterns of these lesions by regres-
sion analysis. Forty-four tumors exhibited growth
and 26 did not. In a regression analysis, 16 of the
tumors that grew followed an exponential growth
pattern and 15 exhibited linear growth patterns.
Two patients with meningioma of an exponential
growth pattern underwent surgical removal. They
consisted of an atypical and a meningothelial men-
ingioma with a relatively high MIB-1 staining in-
dex : 5.8% and 9.0%. These results are similar to our
experience.
Various predictive factors for tumor growth such
as age, sex, tumor volume, and calcification, MRI
T2 were reported. We analyzed the relationship of
the MIB-1 staining indices to the characteristics of
342 consecutive patients with meningioma surgically
removed between 1995 and 2004 (2). Logistic re-
gression analysis demonstrated that male, recur-
rence, non skull-base, absence of calcification were
independent risk factors for a high MIB-1 staining
index (3.0) ; age, symptomatic, volume, multiplic-
ity, and edema were not. These results indicate
that the growth rate of symptomatic meningiomas
may almost be the same as that of incidental men-
ingiomas.
In conclusion, incidentally-found meningiomas
need a careful follow-up. One fourth of the men-
ingiomas are of atypical or malignant grade once
they have shown signs of growing. Attention should
be paid to this fact because the management of
these meningiomas is completely different from the
benign types (17).
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